Compare OBK & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBK | AORT |
|---|---|---|
| Founded | 1912 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 2.1B |
| IPO Year | 2018 | 1993 |
| Metric | OBK | AORT |
|---|---|---|
| Price | $38.30 | $46.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | $43.00 | ★ $49.36 |
| AVG Volume (30 Days) | 140.8K | ★ 358.0K |
| Earning Date | 01-21-2026 | 11-06-2025 |
| Dividend Yield | ★ 1.56% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.91 | N/A |
| Revenue | $325,588,000.00 | ★ $422,646,000.00 |
| Revenue This Year | $13.94 | $15.97 |
| Revenue Next Year | $6.04 | $10.96 |
| P/E Ratio | $20.08 | ★ N/A |
| Revenue Growth | N/A | ★ 9.81 |
| 52 Week Low | $28.80 | $21.97 |
| 52 Week High | $41.17 | $48.25 |
| Indicator | OBK | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 58.18 | 51.71 |
| Support Level | $38.05 | $45.75 |
| Resistance Level | $38.92 | $48.00 |
| Average True Range (ATR) | 0.74 | 1.39 |
| MACD | -0.16 | 0.03 |
| Stochastic Oscillator | 39.46 | 60.32 |
Origin Bancorp Inc is a financial holding company. The bank provides a broad range of financial services to businesses, municipalities, high-net-worth individuals, and retail clients. The bank principally operates in one business segment, community banking. The bank is engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans. The bank generates the majority of its revenue from interest earned on loans and investments, service charges, and fees on deposit accounts.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.